Show simple item record

dc.creatorAiello, Allison E.en
dc.creatorKing, Nicholas B.en
dc.creatorFoxman, B.en
dc.date.accessioned2016-01-08T23:28:00Zen
dc.date.available2016-01-08T23:28:00Zen
dc.date.created2006-11en
dc.date.issued2006-11en
dc.identifierdoi:10.2105/AJPH.2005.077214en
dc.identifier.bibliographicCitationAmerican Journal of Public Health 2006 November; 96(11): 1910-1914en
dc.identifier.urihttp://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Ethical+conflicts+in+public+health+research+and+practice:+antimicrobial+resistance+and+the+ethics+of+drug+development&title=American+Journal+of+Public+Health+&volume=96&issue=11&date=2006-11&au=Aiello,+Allison+E.;+King,+Nicholas+B.;+Foxman,+B.en
dc.identifier.urihttp://dx.doi.org/10.2105/AJPH.2005.077214en
dc.identifier.urihttp://hdl.handle.net/10822/969543en
dc.description.abstractSince the 1960s, scientists and pharmaceutical representatives have called for the advancement and development of new antimicrobial drugs to combat infectious diseases. In January 2005, Senate Majority Leader Bill Frist (R-TN), MD, introduced a biopreparedness bill that included provisions for patent extensions and tax incentives to stimulate industry research on new antimicrobials. Although government stimulus for private development of new antimicrobials is important, it does not resolve long-standing conflicts of interest between private entities and society. Rising rates of antimicrobial resistance have only exacerbated these conflicts. We used methicillin-resistant Staphylococcus aureus as a case study for reviewing these problems, and we have suggested alternative approaches that may halt the vicious cycle of resistance and obsolescence generated by the current model of antimicrobial production.en
dc.formatArticleen
dc.languageenen
dc.sourceeweb:300337en
dc.subjectDrugsen
dc.subjectEthicsen
dc.subjectGovernmenten
dc.subjectHealthen
dc.subjectIncentivesen
dc.subjectIndustryen
dc.subjectPublic Healthen
dc.subjectResearchen
dc.subject.classificationHealth Careen
dc.subject.classificationDrugs and Drug Industryen
dc.subject.classificationBusiness Ethicsen
dc.subject.classificationEconomics of Health Careen
dc.titleEthical Conflicts in Public Health Research and Practice: Antimicrobial Resistance and the Ethics of Drug Developmenten
dc.provenanceCitation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database.en
dc.provenanceCitation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown.en


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2022 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885